X-group (possible homology)

7579 alpha/beta-Hydrolases

Ligands and drugs

14,574
Member domains
5,070
with ligand contacts (≤ 4 Å)
34.8% of members
4,453
with DrugDomain annotations
30.6% of members
3,062
with a DrugBank compound
21.0% of members

Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.

Chemical profile

ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.

445
Proteins with classified ligands
19
Superclasses bound (of 23)
10.2
Superclasses per 20 proteins
broader than 97% of the 256 X-groups with enough proteins to compare (median 7.6)

The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.

SuperclassProteinsExpected
0.25×observed / expected4×
RatioSignificance
Phenylpropanoids and polyketides289.13.07×q < 0.0001
Benzenoids9332.12.90×q < 0.0001
Organosulfur compounds189.01.99×q = 0.01
Homogeneous non-metal compounds16494.41.74×q < 0.0001
Organic acids and derivatives11367.91.66×q < 0.0001
Organic nitrogen compounds2214.01.57×q = 0.06
Organic oxygen compounds12987.41.48×q < 0.0001
Lipids and lipid-like molecules5848.91.19×q = 0.23
Organoheterocyclic compounds6067.50.89×q = 0.43
Homogeneous metal compounds164215.40.76×q < 0.0001
Mixed metal/non-metal compounds19.20.11×q = 4.6e-3
Nucleosides, nucleotides, and analogues7121.30.06×q < 0.0001
Organophosphorus compounds70.247×not tested
Organometallic compounds40.66.40×not tested
Organohalogen compounds61.34.80×not tested
Organic 1,3-dipolar compounds10.42.73×not tested
Alkaloids and derivatives41.52.67×not tested
Organic salts10.52.19×not tested
Hydrocarbons33.10.98×not tested
enriched (q < 0.05)depleted (q < 0.05)not significantnot tested (expected < 5)

Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.

DrugBank compounds

DrugBankPDB ligandNameDomains
DB00141NAGN-Acetylglucosamine1,034
DB03721SIAN-acetyl-alpha-neuraminic acid61
DB02811DEPDiethyl phosphonate50
DB03793BEZBenzoic acid33
DB01992COACoenzyme A31
DB04417NPOP-Nitrophenol25
DB03313CSCCephalosporin C24
DB09459TLAL-tartaric acid22
DB07767FERFerulic acid20
DB00145GLYGlycine19
DB03297PMSBenzylsulfonic acid19
DB03796PLMPalmitic Acid19
DB14756SRTmeso-Tartaric acid17
DB03345BMEMercaptoethanol16
DB00172PROProline15
DB03085GOAGlycolic acid15
DB03568BUAButyric Acid14
DB07821GD7(1R)-1,2,2-trimethylpropyl (R)-methylphosphinate14
DB02175MLAMalonic acid13
DB02226TZ43,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium13

Most frequently bound compounds

PDB ligandNameDomains in contact
NAG2-acetamido-2-deoxy-beta-D-glucopyranose1,006
CLCHLORIDE ION865
CAmetalCALCIUM ION433
NAmetalSODIUM ION244
MGmetalMAGNESIUM ION141
ZNmetalZINC ION118
P6GHEXAETHYLENE GLYCOL114
KmetalPOTASSIUM ION82
SIAN-acetyl-alpha-neuraminic acid68
DEPDIETHYL PHOSPHONATE52
BEZBENZOIC ACID40
PG02-(2-METHOXYETHOXY)ETHANOL36
HI64-(AMINOCARBONYL)-1-[({2-[(E)-(HYDROXYIMINO)METHYL]PYRIDINIUM-1-YL}METHOXY)METHYL]PYRIDINIUM34
PMSphenylmethanesulfonic acid33
TLAL(+)-TARTARIC ACID32
6NAHEXANOIC ACID31
COACOENZYME A31
TMOtrimethylamine oxide31
CDmetalCADMIUM ION30
MRD(4R)-2-METHYLPENTANE-2,4-DIOL30